Mushroom Atlas

Shiitake Mushroom Benefits

What this page covers: named human research on whole shiitake, lentinan, and AHCC, three different products sold or studied under the shiitake name. It does not evaluate identification, cooking, or the raw-shiitake dermatitis reaction; see the Shiitake ID & nutrition page for that. It does not make treatment claims.
In one line

One RCT found eating 5-10 g/day of whole shiitake for 4 weeks raised immune markers in healthy adults. Lentinan and AHCC are separate shiitake-derived extracts, studied separately, with their own distinct (and more limited) evidence; results for one don't transfer to the others.

Whole shiitake: the clearest human evidence on this page

Per Dai et al., 2015, Journal of the American College of Nutrition, a randomized trial gave 52 healthy adults (ages 21-41) either 5 or 10 grams per day of dried shiitake for 4 weeks. Compared to baseline, the trial found γδ-T cells up 60% (P<.0001), NK-T cells doubled (P<.0001), increased salivary IgA (a mucosal-immunity marker), and reduced CRP (a systemic-inflammation marker). This is one trial, in healthy young adults, over 4 weeks, measuring immune markers, not disease outcomes.

Lentinan: a different extract, a different route

Lentinan is a purified polysaccharide extracted from shiitake, administered intravenously, and approved as an adjuvant cancer drug in Japan since 1985. Per Memorial Sloan Kettering's summary, results are mixed across the roughly 40 trials conducted: some studies suggest extended survival when added to chemotherapy for stomach, colorectal, pancreatic, and liver cancers, while a prostate cancer trial found no benefit. Every lentinan trial MSK summarizes used intravenous administration under medical supervision, not an oral capsule from a retail shelf; no source on this page shows an oral lentinan supplement produces the same effect.

AHCC: a third product, oral but preliminary

AHCC (Active Hexose Correlated Compound) is a standardized extract made from cultured shiitake mycelia, sold as an oral supplement. Per Kamiyama et al., 2022, Integrative Cancer Therapies, 29 patients took 1 g of AHCC three times daily for 2 years after curative surgery for hepatocellular carcinoma (25 completed the full course); 2-year recurrence-free survival was 55.2% among all treated patients and 48% among those who completed treatment without discontinuing. The authors describe their own study as single-armed, non-randomized, open-label, and uncontrolled, note the patient count was small, and call for a randomized controlled trial to confirm the result before drawing firmer conclusions.

Shiitake-derived products compared by what was actually tested
FormWhat was testedSourceFinding
Whole mushroom (eaten)5 or 10 g/day dried shiitake, 4 weeks, in healthy adultsDai et al., 2015, Journal of the American College of Nutritionγδ-T cells up 60% (P<.0001), NK-T cells doubled (P<.0001), salivary IgA increased, CRP reduced
Lentinan (IV extract)Purified polysaccharide, administered intravenously, approved as an oncology adjuvant drug in Japan since 1985~40 clinical trials per a PubMed count cited by multiple review sources; summarized by Memorial Sloan KetteringMixed results across cancer types per MSK's summary: some studies show extended survival with chemotherapy in stomach, colorectal, pancreatic, and liver cancers; a prostate cancer trial found it ineffective
AHCC (oral mycelium extract)1 g, 3x/day, 2 years, in 29 post-hepatectomy liver cancer patients (25 completed)Kamiyama et al., 2022, Integrative Cancer Therapies2-year recurrence-free survival 55.2% (all treated) / 48% (completers); single-arm, non-randomized, uncontrolled, small sample, per the authors' own stated limitations

Safety

Per MSK's summary, reported reactions to shiitake and its extracts include skin inflammation, photosensitivity, gastrointestinal upset, eosinophilia, and a distinctive "flagellate dermatitis" (whip-like, linear, reddened wheals), along with rarer reports of hypersensitivity pneumonitis and small bowel obstruction. This page doesn't evaluate individual medication interactions; anyone with a mushroom allergy, anyone pregnant or breastfeeding, and anyone on immune-modulating medication should talk to a doctor first. For the specific raw-vs-cooked dermatitis mechanism and identification traits, see the Shiitake ID page.

For dosing detail and how these forms compare in typical retail servings, see Shiitake Dosage & Consumption.

Ways to take it

Shiitake shows up in several formats beyond capsules: mushroom coffee blends, gummies, and multi-species blends. Check each format's page for what it discloses; none of them are compared against each other on this page.

Frequently Asked Questions

What are shiitake mushroom's studied benefits?

The clearest human evidence for eating whole shiitake comes from one RCT: Dai et al., 2015, gave 52 healthy adults 5 or 10 g/day of dried shiitake for 4 weeks and found increased γδ-T cells, doubled NK-T cells, higher salivary IgA, and lower CRP, markers of immune activity and reduced inflammation. This is one trial in healthy adults, not a disease-outcome study.

What's the difference between shiitake, lentinan, and AHCC?

Three different things sold or studied under the shiitake name. Whole shiitake is the mushroom itself, eaten or in whole-mushroom supplements. Lentinan is a purified polysaccharide extract, administered intravenously and approved as a cancer-adjuvant drug in Japan since 1985, not sold as an oral US supplement. AHCC is a separate standardized extract made from cultured shiitake mycelia, taken orally, studied in its own smaller trials. Evidence for one doesn't automatically apply to the others.

Does lentinan work when taken orally instead of by IV?

The trials behind lentinan's Japanese oncology-adjuvant approval used intravenous administration, not an oral capsule. No source used on this page establishes that an oral lentinan supplement delivers the same effect as the IV extract studied in those trials.

Is AHCC's cancer-recurrence result reliable?

Treat it as preliminary. Kamiyama et al., 2022 was a single-arm study with no control group and no blinding, in a small group (29 patients, 25 completing), and the authors themselves stated the design's limitations and called for a randomized controlled trial to confirm the result.

Is shiitake safe to eat?

For cooking and identification safety, including the raw-shiitake dermatitis reaction some people get, see the identification page linked below; this page covers research on studied benefits, not identification or preparation safety.

Sources